- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05322317
Advance Care Planning (ACP) in Primary Care for Dementia (ADVANCE-PC)
Testing Critical Components for a Trial of Advance Care Planning in Primary Care for Dementia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim 1: To assess the feasibility, acceptability, and content utility of the ECHO program among the clinicians in the participating primary care clinics. Data will be collected to assess successful program implementation and participant engagement. We will document outreach efforts, reporting why clinics decline to participate and as well as the initial motivations of those who agree. Data will be collected from participating clinicians: a pre-training questionnaire about their prior experience with ACP and dementia; feedback at the end of each session; and a longer questionnaire at the end of the training that measures intentions to engage in ACP, their understanding of dementia, their confidence in engaging patients and families in ACP, and what barriers they expect to encounter. Attendance will be documented, and ECHO sessions will be recorded so participation and trainee engagement can be assessed. At the end of the follow-up period, clinicians will participate in interviews focused on barriers to and facilitators of ACP in the context of dementia. Feasibility and acceptability of this intervention will be evaluated using descriptive and qualitative analyses of these data.
Aim 2: To pilot test the ascertainment of outcomes for the ADVANCE-PC program in the 3-month period when trained clinicians are attempting to conduct ACP routinely in their clinics. The primary outcome will be the proportion of patients with dementia and/or their care partners seen by participating clinicians who are engaged in ACP. To pilot test pragmatic assessment of this outcome, we will work with clinics to determine how the number of patients with dementia seen in a defined period (the denominator) and number who are engaged in ACP (the numerator) can be efficiently identified in by each clinic using their electronic health record (EHR). We will collect information on EHR functionality and current dementia and ACP documentation during Months 1-3 and integrate support for documentation and measurement into the training. Our secondary outcomes are clinician confidence, intentions, and behavior related to ACP. These will be evaluated during the ECHO program using questionnaires modeled after data collection activities routinely used by clinics for quality improvement and formally measured and analyzed using research questionnaires pre and post completion of the ECHO program and a semi structured interview at the end of the follow-up period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Clinic Level
The program will be offered to six primary care clinics. Each must meet the following criteria:
- Be a member in a practice-based research network (PBRN) within the Meta-network Learning and Research Center (Meta-LARC),
- Have a functional EHR,
- Have leadership that agrees to clinic participation, and
- Is willing to attempt to track and report the number of eligible patients (those with dementia seen in the clinic by program-trained clinicians) and the number of these patients and/or care partners that received ACP from these program-trained clinicians during a 5-month follow-up period.
Clinician/Staff Level
Within participating clinics, primary care clinicians and other staff must meet all the following inclusion criteria to participate in the training program and the research questionnaire/interview:
- Willing to participate in ECHO sessions,
- Willing to work on ACP implementation between sessions, and
- Be highly likely to have visits with at least 8 patients with dementia and/or their care partners in a 5-month follow-up period.
Adults of any age and pregnant people will be allowed to participate. Primary care clinicians and staff will all be over 18 years old and there is no maximum age limit for participation. It is possible that a primary care clinician or staff member who participates may be pregnant. This research does not inquire about pregnancy status and there is no added risk to the fetus in including a pregnant person in professional training.
Exclusion Criteria:
Anyone meeting one or more of the exclusion criteria listed here will be excluded. We will exclude:
- Children and adolescents, as the target population is primary care clinicians, patient care team members, and primary care clinic staff;
- Clinicians who do not provide primary care;
- Primary care clinicians who do not care for patients with dementia; and
- Primary care clinics that do not have sufficient clinicians (6 clinicians or team members) or sufficient patients (at least 8 patients each) with dementia to meet the pilot test targets.
There will be no systematic exclusion of participants based on age, gender or race, and/or ethnicity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Pilot participants
Participants will participate in ADVANCE-PC training via ECHO and will receive practice facilitation support, if needed. To assess the feasibility of the ADVANCE-PC training and implementation support, research data will be collected from participating clinicians at three time points. Two data collection points will be pre and post ECHO program training questionnaires about attitudes, experience, and intentions related to ACP and dementia. The third will be an interview at the end of the follow-up period, focusing on barriers to and facilitators of ACP in the context of dementia and the impact of the training and implementation support. Feasibility and acceptability of this intervention will be evaluated using descriptive and qualitative analyses of these data. |
To assess the feasibility of using a technology-based platform to deliver the ADVANCE-PC program to multiple primary care clinics.
This model will be based on the ECHO program, a tele-mentoring program which uses communications technology to provide facilitated education, case review, and peer-to-peer problem solving remotely.
Our working hypothesis is that the use of ECHO will be efficient (allowing several clinicians and teams to be supported simultaneously while creating a community of practice), feasible (that clinicians will enroll and share experiences via mentoring, guidance, feedback, and didactic education), and have the potential to impact patients as clinicians perceptions shift to favor ACP, their skills increase, and they are able to integrate ACP for patients with dementia into their clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of enrolled participants who attend 80% of ECHO program sessions
Time Frame: 5 months after start of program
|
number of participants who attended 80% of sessions/number of enrolled participants
|
5 months after start of program
|
|
Proportion of patients with dementia and/or their care partners seen by participating clinicians who are engaged in ACP.
Time Frame: 8 months after start of program
|
Primary care clinics will identify: patients with dementia and/or their care partners who have visits with participating clinicians during the study period (denominator) and track the number of these people who are engaged in advance planning during the project period (numerator)
|
8 months after start of program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participating clinician satisfaction rating: questionnaire designed for this study
Time Frame: 8 months from start of ECHO program
|
A score created by combining 3 items from our study questionnaire: willingness to recommend the program to others, rating of relevance to their practice, and satisfaction with program content.
|
8 months from start of ECHO program
|
|
Percentage of enrolled participants who plan to continue to engage patients with dementia in ACP
Time Frame: 8 months after start of program
|
number of participants who respond Yes to an item on the project questionnaire that asks if they will continue with ACP.
|
8 months after start of program
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Annette M Totten, PhD, Oregon Health and Science University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00023109
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
NYU Langone HealthRecruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
Clinical Trials on ADVANCE-PC training via ECHO
-
VA Office of Research and DevelopmentLouisiana State University Health Sciences Center ShreveportCompletedParkinson's Disease
-
Johns Hopkins UniversityCompletedVitiligo | Dermatology/Skin - OtherUnited States
-
University of PittsburghNational Cancer Institute (NCI)Active, not recruiting
-
St. Jude Children's Research HospitalRecruitingBrain TumorUnited States
-
Milton S. Hershey Medical CenterNational Cancer Institute (NCI)CompletedHuman Papillomavirus Vaccines | Adolescent Health ServicesUnited States
-
Far Eastern Memorial HospitalCompletedAged | Dysphonia | Speech Therapy
-
CentraCareRecruitingFluid ResponsivenessUnited States
-
Bryan DennyNational Institute on Aging (NIA)RecruitingStress | Emotions | Emotion Regulation | Psychological | Caregivers | PsychophysiologyUnited States
-
Norwegian University of Science and TechnologyUllevaal University HospitalTerminated
-
Universidad de ZaragozaCompleted